PharmIdea provides contract development and small-batch contract manufacturing of sterile products in vials, in lyophilised and liquid forms.
The company’s services also include technology development, validation, elaboration of specifications and test methods, stability studies, as well as all other documentation development for process or product registration.
PharmIdea also provides contract manufacturing of investigational medical products (IMP) for phase I to III clinical trials. Products: Atosiban, Zoledronic acid, Bendamustine, Bortezomib.
PharmIdea offers the contract manufacturing of cyto-toxic solutions and freeze-dried products including laboratory-scale formulation batches, small-scale batches and clinical-trial materials. PharmIdea develops sterile oncology drugs and carries out validation techniques on sterile liquids and freeze-dried vials.
